dc.contributor.author | Neelakantan, Nithya | en_US |
dc.contributor.author | Narayanan, Madanagopal | en_US |
dc.contributor.author | de Souza, Russell J | en_US |
dc.contributor.author | van Dam, Rob M | en_US |
dc.date.accessioned | 2014-03-11T13:25:42Z | |
dc.date.issued | 2014 | en_US |
dc.identifier.citation | Neelakantan, Nithya, Madanagopal Narayanan, Russell J de Souza, and Rob M van Dam. 2014. “Effect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: a meta-analysis of clinical trials.” Nutrition Journal 13 (1): 7. doi:10.1186/1475-2891-13-7. http://dx.doi.org/10.1186/1475-2891-13-7. | en |
dc.identifier.issn | 1475-2891 | en |
dc.identifier.uri | http://nrs.harvard.edu/urn-3:HUL.InstRepos:11879528 | |
dc.description.abstract | Background and aim Fenugreek is a herb that is widely used in cooking and as a traditional medicine for diabetes in Asia. It has been shown to acutely lower postprandial glucose levels, but the long-term effect on glycemia remains uncertain. We systematically reviewed clinical trials of the effect of fenugreek intake on markers of glucose homeostasis. Methods: PubMed, SCOPUS, the Cochrane Trials Registry, Web of Science, and BIOSIS were searched up to 29 Nov 2013 for trials of at least 1 week duration comparing intake of fenugreek seeds with a control intervention. Data on change in fasting blood glucose, 2 hour postload glucose, and HbA1c were pooled using random-effects models. Results: A total of 10 trials were identified. Fenugreek significantly changed fasting blood glucose by -0.96 mmol/l (95% CI: -1.52, -0.40; I2 = 80%; 10 trials), 2 hour postload glucose by -2.19 mmol/l (95% CI: -3.19, -1.19; I2 = 71%; 7 trials) and HbA1c by -0.85% (95% CI: -1.49%, -0.22%; I2 = 0%; 3 trials) as compared with control interventions. The considerable heterogeneity in study results was partly explained by diabetes status and dose: significant effects on fasting and 2 hr glucose were only found for studies that administered medium or high doses of fenugreek in persons with diabetes. Most of the trials were of low methodological quality. Conclusions: Results from clinical trials support beneficial effects of fenugreek seeds on glycemic control in persons with diabetes. However, trials with higher methodology quality using a well characterized fenugreek preparation of sufficient dose are needed to provide more conclusive evidence. | en |
dc.language.iso | en_US | en |
dc.publisher | BioMed Central | en |
dc.relation.isversionof | doi:10.1186/1475-2891-13-7 | en |
dc.relation.hasversion | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901758/pdf/ | en |
dash.license | LAA | en_US |
dc.subject | Fenugreek | en |
dc.subject | Trigonella | en |
dc.subject | Nutrition | en |
dc.subject | Glycemia | en |
dc.subject | Diabetes management | en |
dc.subject | Clinical trials | en |
dc.subject | Systematic review | en |
dc.subject | Meta-analysis | en |
dc.title | Effect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: a meta-analysis of clinical trials | en |
dc.type | Journal Article | en_US |
dc.description.version | Version of Record | en |
dc.relation.journal | Nutrition Journal | en |
dash.depositing.author | van Dam, Rob M | en_US |
dc.date.available | 2014-03-11T13:25:42Z | |
dc.identifier.doi | 10.1186/1475-2891-13-7 | * |
dash.contributor.affiliated | Van Dam, Rob | |